Latest news
TransMedics Stock Dips Post Q2 Earnings Miss, Margins Contract - TradingViewTradingView · Wed, 05 Aug 2026 17:42:00 GMTTransMedics Group, Inc. Stock 12‑Month Price Target Cut to $97.3, Implies 20% Upside - TradingViewTradingView · Wed, 05 Aug 2026 14:20:14 GMTTransMedics Group Q2 Earnings Call Highlights - TradingViewTradingView · Wed, 05 Aug 2026 03:03:55 GMTTransmedics Group Inc reports results for the quarter ended June 30 - Earnings Summary - TradingViewTradingView · Tue, 04 Aug 2026 21:37:51 GMTTMDX: Q2 2026 revenue rose 20.7% year-over-year to $189.9M; 2026 guidance increased to $737M–$757M - TradingViewTradingView · Tue, 04 Aug 2026 20:28:46 GMTTransMedics Group, Inc. Q2 2026: Revenue $189.9M, EPS $0.41— 10-Q Summary - TradingViewTradingView · Tue, 04 Aug 2026 20:23:17 GMTTransMedics Group posts Q2 2026 revenue $189.9M, net income $14.7M; raises FY26 revenue guide - TradingViewTradingView · Tue, 04 Aug 2026 20:13:01 GMTTMDX: Record Q2 revenue and raised 2026 guidance highlight strong growth and strategic expansion - TradingViewTradingView · Tue, 04 Aug 2026 20:11:01 GMT